Key Record Dates
ClinicalTrials.gov Identifier: | NCT03191786 |
---|---|
Brief Title: | A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy (IPSOS) |
First Submitted : | June 15, 2017 |
First Submitted that Met QC Criteria : | June 15, 2017 |
First Posted : | June 19, 2017 |
Results First Submitted : | April 18, 2023 |
Results First Posted with QC Comments : | May 11, 2023 |
Results First Submitted that Met QC Criteria : | May 15, 2023 |
Results First Posted : | May 17, 2023 |
Last Update Submitted that Met QC Criteria : | November 1, 2023 |
Last Update Posted : | November 7, 2023 |